1. Home
  2. GDOT vs RGNX Comparison

GDOT vs RGNX Comparison

Compare GDOT & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Dot Corporation $0.001 par value

GDOT

Green Dot Corporation $0.001 par value

HOLD

Current Price

$13.00

Market Cap

742.3M

Sector

Finance

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$12.22

Market Cap

661.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDOT
RGNX
Founded
1999
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
742.3M
661.2M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
GDOT
RGNX
Price
$13.00
$12.22
Analyst Decision
Sell
Strong Buy
Analyst Count
2
7
Target Price
$11.00
$30.29
AVG Volume (30 Days)
1.2M
586.6K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,007,128,000.00
$161,318,000.00
Revenue This Year
$22.03
$198.02
Revenue Next Year
$11.64
$2.67
P/E Ratio
N/A
N/A
Revenue Growth
23.16
91.30
52 Week Low
$6.13
$5.04
52 Week High
$15.41
$13.93

Technical Indicators

Market Signals
Indicator
GDOT
RGNX
Relative Strength Index (RSI) 65.39 52.03
Support Level $10.42 $10.76
Resistance Level $12.64 $13.80
Average True Range (ATR) 0.56 0.79
MACD 0.26 0.10
Stochastic Oscillator 98.29 47.58

Price Performance

Historical Comparison
GDOT
RGNX

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: